Exclusive

Publication

Byline

Location

MAJOR CHANGE FOR RARE DISEASE TREATMENTS ON WAY, SIGNALS MHRA

LONDON, Nov. 2 -- The government of the United Kingdom issued the following news: * New paper published today commits UK to major reform in rare therapies * Bold new rulebook for rare therapies ... Read More


UK FOREIGN SECRETARY "THE PEOPLE OF GAZA CANNOT AFFORD TO WAIT" FOR AID

LONDON, Nov. 2 -- The government of the United Kingdom issued the following news: * The Foreign Secretary is in Jordan today to call for increased aid access as a vital step in the pathway to peace *... Read More


PRESS CONFERENCE BY PM TAKAICHI SANAE AFTER ATTENDING THE APEC ECONOMIC LEADERS' MEETING

TOKYO, Nov. 1 -- Prime Minister and His Cabinet issued the following information: Good afternoon, everyone. As I conclude my visit to Gyeongju, Republic of Korea, for the APEC Economic Leaders' Meeti... Read More


JAPAN-CANADA SUMMIT MEETING

TOKYO, Nov. 1 -- Prime Minister and His Cabinet issued the following information: On November 1st, commencing at 0:30 p.m. local time for approximately 20 minutes, Ms.TAKAICHI Sanae, Prime Minister o... Read More


PM TAKAICHI'S ATTENDANCE AT THE APEC LEADERS' MEETING SESSION II

TOKYO, Nov. 1 -- Prime Minister and His Cabinet issued the following information: On November 1 (local time), from 10:00 a.m. for approximately two and a half hours, the second session of the APEC Le... Read More


APEC Economic Leaders' Meeting and Other Events

TOKYO, Nov. 1 -- Prime Minister and His Cabinet issued the following information: On November 1, 2025 (local time), Prime Minister Takaichi, who is visiting Gyeongju, Republic of Korea, to attend the... Read More


Clinical Trial: Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma

U.S., Nov. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07223411) titled 'Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Per... Read More


Clinical Trial: Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

U.S., Nov. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07223424) titled 'Patient Preference for Subcutaneous vs. Intravenous Immune Therapy' on Oct. 23. Brief Summa... Read More


Clinical Trial: Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs

U.S., Nov. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07222995) titled 'Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback i... Read More


Clinical Trial: Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants

U.S., Nov. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07223216) titled 'Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants' on Oct. 29. B... Read More